Skip to main content Skip to office menu Skip to footer
Capital Icon Minnesota Legislature

Office of the Revisor of Statutes

2024 Minnesota Statutes Index (topics)

PHARMACY BENEFIT MANAGERS (PBMS)

Conflicts of interest, notice, Minn. Statutes 2024 62W.04

Contracts and agreements

Audit terms, charges or assessments, amendments, disclosure, Minn. Statutes 2024 62W.09

Exclusive contracts, drug manufacturers, disclosure, Minn. Statutes 2024 62W.06

Gag clauses, prohibited, Minn. Statutes 2024 62W.11

Good faith and fair dealing, Minn. Statutes 2024 62W.04

Mail order pharmacies, specialty drugs, prompt filling, emergency supply, Minn. Statutes 2024 62W.14

Maximum allowable cost pricing, dispute resolution, appeals, Minn. Statutes 2024 62W.08

Nondisclosure agreements, Minn. Statutes 2024 62W.06

State Employees Group Insurance Program (SEGIP), Minn. Statutes 2024 43A.231

Synchronization, prescription drug refills, Minn. Statutes 2024 62W.10

Definitions, Minn. Statutes 2024 62W.02, 62W.09, 62W.10

Disclosure

Audit terms, amendments, claims audited, Minn. Statutes 2024 62W.09

Exclusive contracts, Minn. Statutes 2024 62W.06

Maximum allowable cost pricing, Minn. Statutes 2024 62W.08

Nondisclosure agreements, Minn. Statutes 2024 62W.06

Pharmacy ownership interests, Minn. Statutes 2024 62W.07

Preferred networks, out-of-pocket costs, Minn. Statutes 2024 62W.077

Prescription drug cost transparency, confidentiality, penalties, Minn. Statutes 2024 62W.06

Specialty pharmacies, out-of-pocket costs, Minn. Statutes 2024 62W.076

Health care taxes, Minn. Statutes 2024 295.50

Licenses and licensing

Generally, Minn. Statutes 2024 62W.03

Network adequacy reports required with applications and renewals, Minn. Statutes 2024 62W.05

Networks of pharmacies

Accreditation standards, Minn. Statutes 2024 62W.05

Adequacy requirements, waivers, reports, mail order pharmacies excluded, Minn. Statutes 2024 62W.05

Federal Drug Pricing Program entities, participation, reimbursement, Minn. Statutes 2024 62W.07

Preferred networks, out-of-pocket costs, disclosure, Minn. Statutes 2024 62W.077

Pharmacy audits, duties regarding, Minn. Statutes 2024 62W.09

Pharmacy ownership interests, disclosure, enrollee incentives and penalties prohibited, Minn. Statutes 2024 62W.07

Prescription Drug Affordability Advisory Council, representation, Minn. Statutes 2024 62J.88

Prescription drugs

Claims, retroactive adjustments, Minn. Statutes 2024 62W.13

Clinician-administered drugs, safety and care requirements, Minn. Statutes 2024 62W.15

Cost transparency, disclosure, confidentiality, penalties, Minn. Statutes 2024 62W.06

Delayed or divided payments prohibited, Minn. Statutes 2024 62Q.81

Disclosure of risks, alternatives, costs, Minn. Statutes 2024 62W.11

Maximum allowable cost pricing, disclosure, dispute resolution, appeals, Minn. Statutes 2024 62W.08

Point of sale payments, limits, Minn. Statutes 2024 62W.12

Prescription Drug Affordability Board, upper payment limit, Minn. Statutes 2024 62J.92

Prescription drugs of substantial public interest reporting, Minn. Statutes 2024 62J.84

Price comparisons, technology platform, Minn. Statutes 2024 43A.231

Rebates and fees, calculation, Minn. Statutes 2024 62W.06

Specialty drugs, prompt filling, mail order pharmacies, emergency supply, Minn. Statutes 2024 62W.14

Substitutions, approval, Minn. Statutes 2024 62W.075

Synchronization, cost-sharing rate, dispensing fees, Minn. Statutes 2024 62W.10

Reports given

Pharmacy audits, Minn. Statutes 2024 62W.09

Prescription Drug Affordability Board, upper payment limit, cost savings, Minn. Statutes 2024 62J.92

Transparency report, Commerce Department, Minn. Statutes 2024 62W.06

Specialty pharmacies, out-of-pocket costs, disclosure, Minn. Statutes 2024 62W.076

Therapeutic alternative drugs, substitution, approval, Minn. Statutes 2024 62W.075